Mary Beth Beasley

Icahn School of Medicine at Mount Sinai ORCID: 0000-0003-2340-1897

2

h-index

2

Publications

2,651

Citations

Publications

2 shown

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Deborah B. Doroshow , Sheena Bhalla , Mary Beth Beasley +7 more

2021 Nature Reviews Clinical Oncology 1397 citations

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

Andrew G. Nicholson , Ming‐Sound Tsao , Mary Beth Beasley +16 more

2021 Journal of Thoracic Oncology 1254 citations

Frequent Co-Authors

Deborah B. Doroshow

Icahn School of Medicine at Mount Sinai

Sheena Bhalla

Icahn School of Medicine at Mount Sinai

Lynette M. Sholl

Brigham and Women's Hospital

Keith M. Kerr

Aberdeen Royal Infirmary

Sacha Gnjatic

Cornell University

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Researcher Info

h-index: 2
Publications: 2
Citations: 2,651
Institution: Icahn School of Medicine at Mount Sinai

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-2340-1897

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.

Academic Output Over Time